
ASN Kidney Translation Series: JASN Late-Breaking Clinical Trials
Show notes
This episode of ASN Kidney Translation Podcast, we review 2 late-breaking clinical trials: empagliflozin in ADPKD and upacicalcet for secondary hyperparathyroidism in hemodialysis. The authors discuss efficacy, safety, and implications for kidney practice
All episodes of Journal of the American Society of Nephrology (JASN)